Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells

Attenuated measles virus (MV) is currently being evaluated in clinical trials as an oncolytic therapeutic agent. Originally used for its lytic activity against tumor cells, it is now admitted that the effectiveness of MV also lies in its ability to initiate antitumor immune responses through the act...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Achard, Carole, Guillerme, Jean-Baptiste, Bruni, Daniela, Boisgerault, Nicolas, Combredet, Chantal, Tangy, Frédéric, Jouvenet, Nolwenn, Grégoire, Marc, Fonteneau, Jean-François
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283625/
https://ncbi.nlm.nih.gov/pubmed/28197384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1261240
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares